EEL
HAE icon

Expect Equity LLC’s Haemonetics HAE Stock Holding History

Expect Equity LLC’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
37,026
+5,645
+18% +$368K 2% 26
2025
Q4 		$2.52M Buy
31,381
+457
+1% +$30.7K 2.43% 18
2025
Q3 		$1.51M Buy
30,924
+9,700
+46% +$600K 1.47% 32
2025
Q2 		$1.58M Buy
21,224
+3,024
+17% +$200K 1.69% 33
2025
Q1 		$1.16M Buy
18,200
+4,100
+29% +$279K 1.3% 39
2024
Q4 		$1.1M Buy
+14,100
New +$1.13M 1.15% 39

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Expect Equity LLC's HAE Position: Q1 2026 in Review

Expect Equity LLC increased its Haemonetics (HAE) stake by 18% in Q1 2026, buying an estimated $368K and bringing the position to 37,026 shares worth $2.09M. The position accounts for 2% of the portfolio, ranked #26.

Expect Equity LLC first reported a position in HAE in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.52M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Expect Equity LLC held 37,026 shares of Haemonetics worth $2.09M as of Q1 2026.
  • Expect Equity LLC bought 5,645 Haemonetics shares in Q1 2026, an estimated $368K.
  • Haemonetics made up 2% of Expect Equity LLC's portfolio in Q1 2026, its #26 holding.
  • Expect Equity LLC first reported a position in Haemonetics in Q4 2024 and has held it in 6 quarters since.
  • Expect Equity LLC's Haemonetics position peaked at $2.52M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Expect Equity LLC's 13F filing for Q1 2026, filed 15 May 2026.